Literature DB >> 16896316

Proteomic analysis of inclusion body myositis.

Jie Li1, Chunyue Yin, Hiroaki Okamoto, Howard Jaffe, Edward H Oldfield, Zhengping Zhuang, Alexander O Vortmeyer, Elisabeth J Rushing.   

Abstract

Sporadic inclusion body myositis (IBM) is the most frequently acquired inflammatory myopathy of late adult life, yet its diagnostic criteria and pathogenesis remain poorly defined. Because effective treatment is lacking, research efforts have intensified to identify specific markers for this debilitating disorder. In this study, proteomic analysis of 4 cases of sporadic IBM was compared with 5 cases of inflammatory myopathy without clinicopathologic features of IBM to distinguish the IBM-specific proteome. Proteins were separated by 2-dimensional polyacrylamide gel electrophoresis and profiled by mass spectrometric sequencing. Expression of most proteins remained unchanged; however, 16 proteins were upregulated and 6 proteins were downregulated in IBM compared with cases of non-IBM inflammatory myopathy. These IBM-specific proteins included apolipoprotein A-I, amyloid beta precursor protein, and transthyretin, which have been associated with amyloidosis; superoxide dismutase, enolase, and various molecular chaperones indicate perturbations in detoxification, energy metabolism, and protein folding, respectively. The IBM-downregulated proteins mainly serve as carriers for muscle contraction and other normal muscle functions. We further applied Western blot and immunohistochemistry to verify the proteomic findings. This study validates proteomics as a powerful tool in the study of muscle disease and indicates a unique pattern of protein expression in IBM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896316     DOI: 10.1097/01.jnen.0000228204.19915.69

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

1.  Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Authors:  Sree Rayavarapu; William Coley; Jack H Van der Meulen; Erdinc Cakir; Kathyayini Tappeta; Travis B Kinder; Blythe C Dillingham; Kristy J Brown; Yetrib Hathout; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2013-12

2.  Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.

Authors:  Kenneth C Parker; Sek Won Kong; Ronan J Walsh; Mohammad Salajegheh; Behzad Moghadaszadeh; Anthony A Amato; Remedios Nazareno; Yin Yin Lin; Bryan Krastins; David A Sarracino; Alan H Beggs; Jack L Pinkus; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

3.  APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.

Authors:  Dana M Niedowicz; Tina L Beckett; Chris J Holler; Adam M Weidner; M Paul Murphy
Journal:  Neurosci Lett       Date:  2010-07-16       Impact factor: 3.046

4.  A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.

Authors:  Tina L Beckett; Christa M Studzinski; Jeffrey N Keller; M Paul Murphy; Dana M Niedowicz
Journal:  Brain Res       Date:  2013-02-12       Impact factor: 3.252

5.  Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.

Authors:  Tina L Beckett; Dana M Niedowicz; Christa M Studzinski; Adam M Weidner; Robin L Webb; Christopher J Holler; Rachel R Ahmed; Harry LeVine; M Paul Murphy
Journal:  Neurobiol Dis       Date:  2010-05-20       Impact factor: 5.996

6.  A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients.

Authors:  Rudolf A Kley; Alexandra Maerkens; Yvonne Leber; Verena Theis; Anja Schreiner; Peter F M van der Ven; Julian Uszkoreit; Christian Stephan; Stefan Eulitz; Nicole Euler; Janbernd Kirschner; Klaus Müller; Helmut E Meyer; Martin Tegenthoff; Dieter O Fürst; Matthias Vorgerd; Thorsten Müller; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2012-10-31       Impact factor: 5.911

7.  Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases.

Authors:  Terrance P O'Hanlon; Zhuoyan Li; Lu Gan; Mark F Gourley; Lisa G Rider; Frederick W Miller
Journal:  Arthritis Res Ther       Date:  2011-11-01       Impact factor: 5.156

8.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20

9.  Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy.

Authors:  A Maerkens; R A Kley; M Olivé; V Theis; P F M van der Ven; J Reimann; H Milting; A Schreiner; J Uszkoreit; M Eisenacher; K Barkovits; A K Güttsches; J Tonillo; K Kuhlmann; H E Meyer; R Schröder; M Tegenthoff; D O Fürst; T Müller; L G Goldfarb; M Vorgerd; K Marcus
Journal:  J Proteomics       Date:  2013-04-30       Impact factor: 4.044

10.  Beyond the binding site: in vivo identification of tbx2, smarca5 and wnt5b as molecular targets of CNBP during embryonic development.

Authors:  Pablo Armas; Ezequiel Margarit; Valeria S Mouguelar; Miguel L Allende; Nora B Calcaterra
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.